Skip to main content
PMC home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 2001 Dec;109(Suppl 6):885–903. doi: 10.1289/ehp.01109s6885

Societal costs of exposure to toxic substances: economic and health costs of four case studies that are candidates for environmental causation.

T Muir 1, M Zegarac 1
PMCID: PMC1240624  PMID: 11744507

Abstract

Four outcomes that evidence suggests are candidates for "environmental causation" were chosen for analysis: diabetes, Parkinson's disease (PD), neurodevelopmental effects and hypothyroidism, and deficits in intelligence quotient (IQ). These are an enormous burden in the United States, Canada, and other industrial countries. We review findings on actual social and economic costs, construct estimates of some of the costs from pertinent sources, and provide several hypothetical examples consistent with published evidence. Many detailed costs are estimated, but these are fragmented and missing in coverage and jurisdiction. Nonetheless, the cumulative costs identified are very large, totaling $568 billion to $793 billion per year for Canada and the United States combined. Partial Canadian costs alone are $46 billion to $52 billion per year. Specifics include diabetes (United States and Canada), $128 billion per year; PD in the United States, $13 billion to $28.5 billion per year; neurodevelopmental deficits and hypothryoidism are endemic and, including estimates of costs of childhood disorders that evidence suggests are linked, amount to $81.5 billion to $167 billion per year for the United States and $2 billion per year in Ontario; loss of 5 IQ points cost $30 billion per year in Canada and $275 billion to $326 billion per year in the United States; and hypothetical dynamic economic impacts cost another $19 billion to $92 billion per year for the United States and Canada combined. Reasoned arguments based on the weight of evidence can support the hypothesis that at least 10%, up to 50% of these costs are environmentally induced--between $57 billion and $397 billion per year.

Full Text

The Full Text of this article is available as a PDF (243.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chrischilles E. A., Rubenstein L. M., Voelker M. D., Wallace R. B., Rodnitzky R. L. The health burdens of Parkinson's disease. Mov Disord. 1998 May;13(3):406–413. doi: 10.1002/mds.870130306. [DOI] [PubMed] [Google Scholar]
  2. Currie C. J., Kraus D., Morgan C. L., Gill L., Stott N. C., Peters J. R. NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care. Diabet Med. 1997 Aug;14(8):686–692. doi: 10.1002/(SICI)1096-9136(199708)14:8<686::AID-DIA434>3.0.CO;2-D. [DOI] [PubMed] [Google Scholar]
  3. Dodel R. C., Singer M., Köhne-Volland R., Szucs T., Rathay B., Scholz E., Oertel W. H. The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis. Pharmacoeconomics. 1998 Sep;14(3):299–312. doi: 10.2165/00019053-199814030-00006. [DOI] [PubMed] [Google Scholar]
  4. Gerard K., Donaldson C., Maynard A. K. The cost of diabetes. Diabet Med. 1989 Mar;6(2):164–170. doi: 10.1111/j.1464-5491.1989.tb02107.x. [DOI] [PubMed] [Google Scholar]
  5. Haddow J. E., Palomaki G. E., Allan W. C., Williams J. R., Knight G. J., Gagnon J., O'Heir C. E., Mitchell M. L., Hermos R. J., Waisbren S. E. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med. 1999 Aug 19;341(8):549–555. doi: 10.1056/NEJM199908193410801. [DOI] [PubMed] [Google Scholar]
  6. Jacobson J. L., Jacobson S. W. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. N Engl J Med. 1996 Sep 12;335(11):783–789. doi: 10.1056/NEJM199609123351104. [DOI] [PubMed] [Google Scholar]
  7. Jönsson B. Diabetes--the cost of illness and the cost of control. An estimate for Sweden 1978. Acta Med Scand Suppl. 1983;671:19–27. doi: 10.1111/j.0954-6820.1983.tb08543.x. [DOI] [PubMed] [Google Scholar]
  8. Klein R. Z., Haddow J. E., Faix J. D., Brown R. S., Hermos R. J., Pulkkinen A., Mitchell M. L. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) 1991 Jul;35(1):41–46. doi: 10.1111/j.1365-2265.1991.tb03494.x. [DOI] [PubMed] [Google Scholar]
  9. LePen C., Wait S., Moutard-Martin F., Dujardin M., Ziégler M. Cost of illness and disease severity in a cohort of French patients with Parkinson's disease. Pharmacoeconomics. 1999 Jul;16(1):59–69. doi: 10.2165/00019053-199916010-00006. [DOI] [PubMed] [Google Scholar]
  10. Lilienfeld D. E., Perl D. P. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology. 1993;12(4):219–228. doi: 10.1159/000110320. [DOI] [PubMed] [Google Scholar]
  11. London E. A. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect. 2000 Jun;108 (Suppl 3):401–404. doi: 10.1289/ehp.00108s3401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. London E. A. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect. 2000 Jun;108 (Suppl 3):401–404. doi: 10.1289/ehp.00108s3401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Morreale de Escobar G., Obregón M. J., Escobar del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab. 2000 Nov;85(11):3975–3987. doi: 10.1210/jcem.85.11.6961. [DOI] [PubMed] [Google Scholar]
  14. Pharoah P. O., Connolly K. J., Ekins R. P., Harding A. G. Maternal thyroid hormone levels in pregnancy and the subsequent cognitive and motor performance of the children. Clin Endocrinol (Oxf) 1984 Sep;21(3):265–270. doi: 10.1111/j.1365-2265.1984.tb03468.x. [DOI] [PubMed] [Google Scholar]
  15. Porterfield S. P., Hendry L. B. Impact of PCBs on thyroid hormone directed brain development. Toxicol Ind Health. 1998 Jan-Apr;14(1-2):103–120. doi: 10.1177/074823379801400109. [DOI] [PubMed] [Google Scholar]
  16. Rice D. C. Issues in developmental neurotoxicology: interpretation and implications of the data. Can J Public Health. 1998 May-Jun;89 (Suppl 1):S31-6, S34-40. [PubMed] [Google Scholar]
  17. Rose G. Environmental factors and disease: the man made environment. Br Med J (Clin Res Ed) 1987 Apr 11;294(6577):963–965. doi: 10.1136/bmj.294.6577.963. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rovet J. F., Daneman D., Bailey J. D. Psychologic and psychoeducational consequences of thyroxine therapy for juvenile acquired hypothyroidism. J Pediatr. 1993 Apr;122(4):543–549. doi: 10.1016/s0022-3476(05)83533-4. [DOI] [PubMed] [Google Scholar]
  19. Rovet J. F., Ehrlich R. Psychoeducational outcome in children with early-treated congenital hypothyroidism. Pediatrics. 2000 Mar;105(3 Pt 1):515–522. doi: 10.1542/peds.105.3.515. [DOI] [PubMed] [Google Scholar]
  20. Rubenstein L. M., Chrischilles E. A., Voelker M. D. The impact of Parkinson's disease on health status, health expenditures, and productivity. Estimates from the National Medical Expenditure Survey. Pharmacoeconomics. 1997 Oct;12(4):486–498. doi: 10.2165/00019053-199712040-00006. [DOI] [PubMed] [Google Scholar]
  21. Rubin R. J., Altman W. M., Mendelson D. N. Health care expenditures for people with diabetes mellitus, 1992. J Clin Endocrinol Metab. 1994 Apr;78(4):809A–809F. doi: 10.1210/jcem.78.4.8157701. [DOI] [PubMed] [Google Scholar]
  22. Salkever D. S. Updated estimates of earnings benefits from reduced exposure of children to environmental lead. Environ Res. 1995 Jul;70(1):1–6. doi: 10.1006/enrs.1995.1038. [DOI] [PubMed] [Google Scholar]
  23. Schwartz J. Low-level lead exposure and children's IQ: a meta-analysis and search for a threshold. Environ Res. 1994 Apr;65(1):42–55. doi: 10.1006/enrs.1994.1020. [DOI] [PubMed] [Google Scholar]
  24. Schwartz J. Societal benefits of reducing lead exposure. Environ Res. 1994 Jul;66(1):105–124. doi: 10.1006/enrs.1994.1048. [DOI] [PubMed] [Google Scholar]
  25. Singer E. Social costs of Parkinson's disease. J Chronic Dis. 1973 Apr;26(4):243–254. doi: 10.1016/0021-9681(73)90105-7. [DOI] [PubMed] [Google Scholar]
  26. Szatmari P., Offord D. R., Boyle M. H. Ontario Child Health Study: prevalence of attention deficit disorder with hyperactivity. J Child Psychol Psychiatry. 1989 Mar;30(2):219–230. doi: 10.1111/j.1469-7610.1989.tb00236.x. [DOI] [PubMed] [Google Scholar]
  27. Warner D. C., McCandless R. R., De Nino L. A., Cornell J. E., Pugh J. A., Marsh G. M. Costs of diabetes in Texas, 1992. Diabetes Care. 1996 Dec;19(12):1416–1419. doi: 10.2337/diacare.19.12.1416. [DOI] [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES